Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Slides: 1–8 of 8
Add to tray Remove from tray

Overview: Results for Treatment of CDI with Standard Antibiotics

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: antibiotics | fidaxomicin | results | treatment | vancomycin | overview
Add to tray Remove from tray

Overview: Conclusions

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: conclusions | diagnostic assays | patient outcomes | prevention | treatment | overview
Add to tray Remove from tray

Introduction: Incidence of C.difficile Infection (CDI)

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | healthcare-associated infection | morbidity | mortality | incidence
Add to tray Remove from tray

Introduction: C.difficile Etiology

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | hypervirulent | risk factors | toxigenic | etiology
Add to tray Remove from tray

Assays Commonly Used in CDI Diagnostics

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | C. difficile culture | cytotoxicity assay | immunoassays | toxin gene detection | diagnostic assays
Add to tray Remove from tray

Comparative Effectiveness of Standard Antibiotic Treatment for CDI

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: antibiotic treatment | C. difficile Infection (CDI) | FDA-approved antibiotics | organism strain
Add to tray Remove from tray

Comparative Effectiveness of Standard Antibiotic Treatment for CDI

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | initial cure rate | non-North American Pulsed Field type 1 strain | recurrence rates | antibiotic treatment
Add to tray Remove from tray

Background: Causes of Musculoskeletal Pain

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: musculoskeletal pain | nonrheumatic cause | sprain | strain | overuse | normal body growth | rheumatic cause | juvenile idiopathic arthritis | pediatric systemic lupus erythematosus | spondyloarthropathy | enthesitis-related arthritis | juvenile ankylosing spondylitis | reactive arthritis | acute rheumatic fever | Henoch-Schönlein purpura
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364